Physicochemical Properties
| Molecular Formula | C22H24CL3FN4 |
| Molecular Weight | 469.810165405273 |
| Exact Mass | 468.105 |
| CAS # | 2387510-87-2 |
| Related CAS # | BI-9321;2387510-86-1 |
| PubChem CID | 145874876 |
| Appearance | Light yellow to yellow solid powder |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 30 |
| Complexity | 491 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | Cl.Cl.Cl.FC1C=CC2C(C=1)=NC=CC=2C1=C(C2C(C)=CC(CN)=CC=2C)N=CN1C |
| InChi Key | DCDXMBVQCRHZMW-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C22H21FN4.3ClH/c1-13-8-15(11-24)9-14(2)20(13)21-22(27(3)12-26-21)18-6-7-25-19-10-16(23)4-5-17(18)19;;;/h4-10,12H,11,24H2,1-3H3;3*1H |
| Chemical Name | [4-[5-(7-fluoroquinolin-4-yl)-1-methylimidazol-4-yl]-3,5-dimethylphenyl]methanamine;trihydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | The BI-9321 triHClide domain's methyl-lysine binding site exhibits submicromolar in vitro activity and 1 μM cellular target binding. When used alone, BI-9321 triHClide inhibits MOLM-13 cell growth and increases the expression of Myc messenger RNA [1]. |
| References |
[1]. Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3. Nat Chem Biol. 2019 Aug;15(8):822-829. |
Solubility Data
| Solubility (In Vitro) |
DMSO : ~250 mg/mL (~532.13 mM) H2O : ~25 mg/mL (~53.21 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 25 mg/mL (53.21 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 250.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 25 mg/mL (53.21 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 250.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 25 mg/mL (53.21 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 250.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 4: 100 mg/mL (212.85 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1285 mL | 10.6426 mL | 21.2852 mL | |
| 5 mM | 0.4257 mL | 2.1285 mL | 4.2570 mL | |
| 10 mM | 0.2129 mL | 1.0643 mL | 2.1285 mL |